Autonomic Modulation and Facial Expression in Autism Spectrum Disorder
NCT ID: NCT02997566
Last Updated: 2020-06-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
55 participants
OBSERVATIONAL
2016-08-31
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Course of Face-to-face Interactions in Adults With Autism
NCT06925308
Neurotherapy to Promote Emotion Recognition in Autism
NCT03376373
The Development of Autistic Children Based on Mothers´Response in Autism Behavior Checklist
NCT00725556
Outcomes of Emotion Regulation Therapy in Young Autistic Adults
NCT05341505
Autistic Eye Contact?
NCT06921876
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Autistic Disorder
Age: 3 to 14 years-old Gender: male and female Autism Spectrum Disorder
Autonomic evaluation
Typical
Age: 3 to 14 years-old Gender: male and female Typical
Autonomic evaluation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Autonomic evaluation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Participants with an error superior to 5% in the RR intervals series.
3 Years
14 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidade Estadual Paulista Júlio de Mesquita Filho
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Luiz Carlos Marques Vanderlei
PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Luiz Carlos M Vanderlei, PhD
Role: PRINCIPAL_INVESTIGATOR
Universidade Estadual Paulista Júlio de Mesquita Filho
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universidade Estadual Paulista Júlio de Mesquita Filho
Presidente Prudente, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
57347916.5.0000.5402
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.